US pharmaceutical giant Pfizer Inc wants to buy AstraZeneca PLC in a deal that could value its smaller British rival at more than US$100 billion, creating a new behemoth on the global pharmaceuticals scene.
Pfizer yesterday confirmed that it made a bid approach to AstraZeneca in January and said it had contacted its British rival again on Saturday last week seeking discussions about a takeover.
AstraZeneca shares jumped 15 percent in early trading.
Photo: Bloomberg
The takeover, if it happens, would be one of the largest-ever deals in the industry. Pfizer’s renewed approach comes amid a wave of pharmaceutical mergers and acquisitions.
In a statement to the London stock market, Pfizer said AstraZeneca had declined to engage in discussions on both occasions and the US group said it was now considering its options.
Pfizer’s original proposal, made to the board of AstraZeneca on Jan. 5, included a combination of cash and shares and would have valued AstraZeneca’s shares at £46.61 each — a premium of around 30 percent at the time.
Pfizer said it was now considering a possible transaction in which AstraZeneca shareholders would again receive a significant premium for their shares.
AstraZeneca shares closed at £40.80 on Friday last week, valuing it at £51.5 billion (US$86.64 billion) against the indicated Pfizer bid level in January of £58.8 billion.
Given that Pfizer is likely to have to offer more this time, due to a rise in AstraZeneca shares since January, the final value of any deal could be considerably above US$100 billion.
An AstraZeneca spokeswoman said the company had no immediate comment on the Pfizer statement, adding that the company would be considering its response.
Buying AstraZeneca would give Pfizer a number of promising — though still risky — experimental cancer medicines known as immunotherapies that boost the immune system to fight tumors and could generate significant cost savings.
Acquiring a foreign company also makes sense for Pfizer, because it has tens of billions of dollars accumulated through foreign subsidiaries, which if repatriated to the US would be heavily taxed.
Pfizer has a long track record of making major acquisitions, with the US$68 billion purchase of Wyeth Pharmaceuticals Inc in 2009 its last major deal, after earlier acquisitions of Pharmacia Corp and Warner Lambert Co.
The drugmaker has been divesting certain operations and mega-mergers have fallen out of fashion in the pharmaceuticals industry following skepticism about how well some of them have worked.
However, Pfizer chief executive officer Ian Read said he was ready to consider large deals that made sense, adding that buying AstraZeneca would “maintain the flexibility for the potential future separation of our businesses.”
The deal could complement both Pfizer’s innovative drug businesses and also its established products business — comprising older and off-patent medicines — which many analysts expect to be eventually spun off.
“We believe that a transaction would further strengthen our ability to generate strong and consistent cash flow, targeted for both investment in our business and return to shareholders, while at the same time offering an efficient operating structure and the anticipated realization of attractive synergies,” Read said.
DECOUPLING? In a sign of deeper US-China technology decoupling, Apple has held initial talks about using Baidu’s generative AI technology in its iPhones, the Wall Street Journal said China has introduced guidelines to phase out US microprocessors from Intel Corp and Advanced Micro Devices Inc (AMD) from government PCs and servers, the Financial Times reported yesterday. The procurement guidance also seeks to sideline Microsoft Corp’s Windows operating system and foreign-made database software in favor of domestic options, the report said. Chinese officials have begun following the guidelines, which were unveiled in December last year, the report said. They order government agencies above the township level to include criteria requiring “safe and reliable” processors and operating systems when making purchases, the newspaper said. The US has been aiming to boost domestic semiconductor
Nvidia Corp earned its US$2.2 trillion market cap by producing artificial intelligence (AI) chips that have become the lifeblood powering the new era of generative AI developers from start-ups to Microsoft Corp, OpenAI and Google parent Alphabet Inc. Almost as important to its hardware is the company’s nearly 20 years’ worth of computer code, which helps make competition with the company nearly impossible. More than 4 million global developers rely on Nvidia’s CUDA software platform to build AI and other apps. Now a coalition of tech companies that includes Qualcomm Inc, Google and Intel Corp plans to loosen Nvidia’s chokehold by going
ENERGY IMPACT: The electricity rate hike is expected to add about NT$4 billion to TSMC’s electricity bill a year and cut its annual earnings per share by about NT$0.154 Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has left its long-term gross margin target unchanged despite the government deciding on Friday to raise electricity rates. One of the heaviest power consuming manufacturers in Taiwan, TSMC said it always respects the government’s energy policy and would continue to operate its fabs by making efforts in energy conservation. The chipmaker said it has left a long-term goal of more than 53 percent in gross margin unchanged. The Ministry of Economic Affairs concluded a power rate evaluation meeting on Friday, announcing electricity tariffs would go up by 11 percent on average to about NT$3.4518 per kilowatt-hour (kWh)
OPENING ADDRESS: The CEO is to give a speech on the future of high-performance computing and artificial intelligence at the trade show’s opening on June 3, TAITRA said Advanced Micro Devices Inc (AMD) chairperson and chief executive officer Lisa Su (蘇姿丰) is to deliver the opening keynote speech at Computex Taipei this year, the event’s organizer said in a statement yesterday. Su is to give a speech on the future of high-performance computing (HPC) in the artificial intelligence (AI) era to open Computex, one of the world’s largest computer and technology trade events, at 9:30am on June 3, the Taiwan External Trade Development Council (TAITRA) said. Su is to explore how AMD and the company’s strategic technology partners are pushing the limits of AI and HPC, from data centers to